[HTML][HTML] Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - Plos one, 2023 - journals.plos.org
Purpose Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
[PDF][PDF] Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - PLoS ONE, 2023 - scienceopen.com
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A
prospective cohort trial Page 1 RESEARCH ARTICLE Ventilatory support and inflammatory …
prospective cohort trial Page 1 RESEARCH ARTICLE Ventilatory support and inflammatory …
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - PLoS …, 2023 - ui.adsabs.harvard.edu
Purpose Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
[HTML][HTML] Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - PLOS …, 2023 - ncbi.nlm.nih.gov
Purpose Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial.
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - PLoS …, 2023 - search.ebscohost.com
Purpose: Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - PloS …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial
M Gysan, C Milacek, C Bal, A Zech, J Brugger, R Milos… - Plos one, 2023 - europepmc.org
Purpose Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
Ventilatory support and inflammatory peptides in hospitalised patients with COVID-19: A prospective cohort trial.
MR Gysan, C Milacek, C Bal, A Zech, J Brugger… - Plos one, 2023 - europepmc.org
Purpose Several studies have shown that SARS-CoV-2 can induce a massive release of
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …
cytokines which contributes to disease severity and mortality. Therefore, cytokine levels in …